Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | KDM5A | P29375 | 2/20 | 0.45 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.45 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 6/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | DRD1 | P21728 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | DRD3 | P35462 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4831575 | 0.93 | KDM5A (0.45) | CA12CA1CA2CA4KDM5A | |
| SCHEMBL9145682 | 0.93 | KDM5A (0.45) | CA12CA1CA2CA4KDM5A | |
| SCHEMBL19945020 | 0.93 | KDM5A (0.45) | CA12CA1CA2CA4KDM5A | |
| Hydrochloric Acid SCHEMBL4796163 | 0.91 | KDM5A (0.44) | KDM5APHF8KDM4CTSHRTDP1 | |
| SCHEMBL1881925 | 0.91 | KDM5A (0.44) | CA12CA1CA2CA4KDM5A | |
| SCHEMBL7568504 | 0.90 | TSHR (0.54) | KDM5APHF8KDM4CTSHRTDP1 | |
| SCHEMBL19040769 | 0.90 | TSHR (0.54) | KDM5APHF8KDM4CTSHRTDP1 | |
| SCHEMBL19821298 | 0.90 | TSHR (0.54) | KDM5APHF8KDM4CTSHRTDP1 | |
| SCHEMBL11512199 | 0.90 | TSHR (0.54) | KDM5APHF8KDM4CTSHRTDP1 | |
| SCHEMBL19821297 | 0.90 | TSHR (0.54) | KDM5APHF8KDM4CTSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 800 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | ROCHAL TECHNOLOGIES LLC (US) | 2023-12-12 | — | — | US | claimed |
| CN-115054529-A | Amino acid type oil-control acne-removing facial cleanser | 广东嘉丹婷日用品有限公司 | 2022-09-16 | — | — | CN | claimed |
| CN-114848523-A | Double-tube facial cleanser | 广东嘉丹婷日用品有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-113855606-A | Ginger shampoo and preparation method thereof | 西藏山南德诺农林产业开发有限责任公司 | 2021-12-31 | — | — | CN | claimed |
| EP-3220741-B1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | ROCHAL IND LLC (US) | 2021-02-24 | — | — | EP | claimed |
| CN-111135108-A | Compound preservative containing amino acid derivatives, preparation method thereof and cosmetics | 广东迪美生物技术有限公司 | 2020-05-12 | — | — | CN | claimed |
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | ROCHAL INDUSTRIES, LLC (US) | 2017-12-21 | — | — | US | claimed |
| CN-107410317-A | Improve the diffusible wet tissue composition in wet tissue fabric and the wet tissue containing said composition | 明进新科技股份有限公司 | 2017-12-01 | — | — | CN | claimed |
| EP-3220741-A1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | Rochal Industries, LLC (US) | 2017-09-27 | — | — | EP | claimed |
| EP-2152845-B1 | HARD SURFACE CLEANING COMPOSITION WITH HYDROPHILIZING AGENT AND METHOD FOR CLEANING HARD SURFACES | SOLVAY USA INC (US) | 2017-03-29 | — | — | EP | claimed |
| US-20020090349-A1 | Process for the biocidal treatment of surface | BERGERON VANCE (FR) | 2002-07-11 | — | — | US | claimed |
| US-5886041-A | SKIN DISORDERS | TRISTRATA TECHNOLOGY, INC. (US) | 1999-03-23 | — | — | US | claimed |
| US-5886042-A | PREVENTION OF IRRITATION BY INCLUDING AN ORGANIC BUFFER, E.G AN AMINO ACID, DIPEPTIDE, CREATINE; SKIN DISORDERS; COSMETICS; PH | TRISTRATA TECHNOLOGY, INC. (US) | 1999-03-23 | — | — | US | claimed |
| US-5883128-A | SKIN DISORDERS | TRISTRATA TECHNOLOGY INC. (US) | 1999-03-16 | — | — | US | claimed |
| US-5702688-A | TREATING SKIN DISORDERS | TRISTRATA TECHNOLOGY, INC. (US) | 1997-12-30 | — | — | US | claimed |
| US-5690967-A | MIXTURE CONTAINING AMPHOTERIC AGENT | TRISTRATA TECHNOLOGY, INC. (US) | 1997-11-25 | — | — | US | claimed |
| US-5684044-A | MIXED WITH AMPHOTERIC OR PSEUDOAMPHOTERIC AGENT | TRISTRATA, INCORPORATED (US) | 1997-11-04 | — | — | US | claimed |
| US-5681853-A | MIXTURE WITH AMPHOTERIC COMPOUND | TRISTRATA TECHNOLOGY, INC. (US) | 1997-10-28 | — | — | US | claimed |
| EP-0413528-B1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | YU RUEY J (US) | 1995-11-15 | — | — | EP | claimed |
| US-5091171-A | Skin disorders | IGI, INC. | 1992-02-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | CUTA, MMP8, MMP1 | CA12 4094/4885CA1 4063/4885CA2 2919/4885 |
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | CUTA, MMP8, MMP1 | CA12 4094/4885CA1 4063/4885CA2 2919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.